Nutanix jumped 14% after posting fiscal second-quarter earnings and revenue that beat analysts' forecasts. Nvidia reported sharply higher quarterly sales and profit, but a narrower profit margin.

Goldman, Sachs & Co. LLC served as financial advisor to RGA ... Farmers and agribusinesses will gain access to a Bushel business account*, offered by... mRESVIA® is Moderna's second approved ...

Improving economic conditions and a more favorable regulatory environment give Goldman Sachs catalysts to benefit from in the ...

Expectations of a banner year in dealmaking have not yet materialized due to worries about inflation and uncertainties over U ...

Goldman Sachs Asset Management is launching its first biodiversity fund for bond investors, in a move it says provides a new product to a market that’s so far been dominated by other asset classes.

Discover why Goldman Sachs remains a top pick with strong ratings, impressive margins, and growth potential in M&A, equity ...

Goldman Sachs Group Inc. said it’s more than 80% of the way to meeting its 2030 goal of putting $750 billion toward ...

Hedge funds exited U.S. tech and media stocks in the two weeks to February 21 at the fastest pace in six months, according to ...

Goldman Sachs analyst Salveen Richter initiated coverage of Summit Therapeutics (SMMT) with a Buy rating and $42 price target a Summit’s lead ...

Goldman Sachs analyst Chris Shibutani initiated coverage of Metsera (MTSR) as an Early-Stage Biotech. Metsera is clinical-stage ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...